{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:16:39Z","timestamp":1789946199658,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T00:00:00Z","timestamp":1649548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T00:00:00Z","timestamp":1649548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s40262-022-01122-5","type":"journal-article","created":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T10:02:32Z","timestamp":1649584952000},"page":"973-983","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Hyperinflammation Reduces Midazolam Metabolism in Critically Ill Adults with COVID-19"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2197-3405","authenticated-orcid":false,"given":"Tim J. L.","family":"Smeets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham J.","family":"Valkenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"van der Jagt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit C. P.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Endeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederik A. M. P. J.","family":"Gommers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian D. T.","family":"Sassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole G. M.","family":"Hunfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,10]]},"reference":[{"issue":"9","key":"1122_CR1","doi-asserted-by":"publisher","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","volume":"46","author":"JW Devlin","year":"2018","unstructured":"Devlin JW, Skrobik Y, Gelinas C, Needham DM, Slooter AJC, Pandharipande PP, et al. Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46(9):e825\u201373.","journal-title":"Crit Care Med"},{"issue":"12","key":"1122_CR2","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1007\/s00134-020-06307-9","volume":"46","author":"G Chanques","year":"2020","unstructured":"Chanques G, Constantin JM, Devlin JW, Ely EW, Fraser GL, Gelinas C, et al. Analgesia and sedation in patients with ARDS. Intensive Care Med. 2020;46(12):2342\u201356.","journal-title":"Intensive Care Med"},{"issue":"3","key":"1122_CR3","first-page":"239","volume":"9","author":"BT Pun","year":"2021","unstructured":"Pun BT, Badenes R, Heras La Calle G, Orun OM, Chen W, Raman R, et al. Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study. Lancet Respir Med. 2021;9(3):239\u201350.","journal-title":"Respir Med."},{"issue":"6","key":"1122_CR4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/clpt.1992.84","volume":"51","author":"JW Mandema","year":"1992","unstructured":"Mandema JW, Tuk B, van Steveninck AL, Breimer DD, Cohen AF, Danhof M. Pharmacokinetic\u2013pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers. Clin Pharmacol Ther. 1992;51(6):715\u201328.","journal-title":"Clin Pharmacol Ther"},{"issue":"8968","key":"1122_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0140-6736(95)91209-6","volume":"346","author":"TM Bauer","year":"1995","unstructured":"Bauer TM, Ritz R, Haberthur C, Ha HR, Hunkeler W, Sleight AJ, et al. Prolonged sedation due to accumulation of conjugated metabolites of midazolam. Lancet. 1995;346(8968):145\u20137.","journal-title":"Lancet"},{"issue":"2","key":"1122_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1124\/dmd.107.018747","volume":"36","author":"ET Morgan","year":"2008","unstructured":"Morgan ET, Goralski KB, Piquette-Miller M, Renton KW, Robertson GR, Chaluvadi MR, et al. Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab Dispos. 2008;36(2):205\u201316.","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"1122_CR7","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/clpt.2008.62","volume":"83","author":"VD Schmith","year":"2008","unstructured":"Schmith VD, Foss JF. Effects of inflammation on pharmacokinetics\/pharmacodynamics: increasing recognition of its contribution to variability in response. Clin Pharmacol Ther. 2008;83(6):809\u201311.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"1122_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jac\/dkw349","volume":"72","author":"A Veringa","year":"2017","unstructured":"Veringa A, Ter Avest M, Span LF, van den Heuvel ER, Touw DJ, Zijlstra JG, et al. Voriconazole metabolism is influenced by severe inflammation: a prospective study. J Antimicrob Chemother. 2017;72(1):261\u20137.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"1122_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/annonc\/mdl321","volume":"18","author":"J Alexandre","year":"2007","unstructured":"Alexandre J, Rey E, Girre V, Grabar S, Tran A, Montheil V, et al. Relationship between cytochrome 3A activity, inflammatory status and the risk of docetaxel-induced febrile neutropenia: a prospective study. Ann Oncol. 2007;18(1):168\u201372.","journal-title":"Ann Oncol"},{"issue":"8","key":"1122_CR10","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1124\/dmd.111.038679","volume":"39","author":"LJ Dickmann","year":"2011","unstructured":"Dickmann LJ, Patel SK, Rock DA, Wienkers LC, Slatter JG. Effects of interleukin-6 (IL-6) and an anti-IL-6 monoclonal antibody on drug-metabolizing enzymes in human hepatocyte culture. Drug Metab Dispos. 2011;39(8):1415\u201322.","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"1122_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1164\/rccm.201510-2114OC","volume":"194","author":"NJ Vet","year":"2016","unstructured":"Vet NJ, Brussee JM, de Hoog M, Mooij MG, Verlaat CW, Jerchel IS, et al. Inflammation and organ failure severely affect midazolam clearance in critically ill children. Am J Respir Crit Care Med. 2016;194(1):58\u201366.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"1122_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1046\/j.1365-2125.2003.01957.x","volume":"57","author":"EL Swart","year":"2004","unstructured":"Swart EL, Zuideveld KP, de Jongh J, Danhof M, Thijs LG, Strack van Schijndel RM. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients. Br J Clin Pharmacol. 2004;57(2):135\u201345.","journal-title":"Br J Clin Pharmacol."},{"issue":"2","key":"1122_CR13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1164\/rccm.202003-0816LE","volume":"202","author":"P van der Zee","year":"2020","unstructured":"van der Zee P, Somhorst P, Endeman H, Gommers D. Electrical impedance tomography for positive end-expiratory pressure titration in COVID-19-related acute respiratory distress syndrome. Am J Respir Crit Care Med. 2020;202(2):280\u20134.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"1122_CR14","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1111\/bcp.13259","volume":"83","author":"LG Franken","year":"2017","unstructured":"Franken LG, Masman AD, de Winter BCM, Baar FPM, Tibboel D, van Gelder T, et al. Hypoalbuminaemia and decreased midazolam clearance in terminally ill adult patients, an inflammatory effect? Br J Clin Pharmacol. 2017;83(8):1701\u201312.","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"1122_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/clpt.1989.182","volume":"46","author":"TB Vree","year":"1989","unstructured":"Vree TB, Shimoda M, Driessen JJ, Guelen PJ, Janssen TJ, Termond EF, et al. Decreased plasma albumin concentration results in increased volume of distribution and decreased elimination of midazolam in intensive care patients. Clin Pharmacol Ther. 1989;46(5):537\u201344.","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"1122_CR16","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2165\/00003495-198428060-00002","volume":"28","author":"JW Dundee","year":"1984","unstructured":"Dundee JW, Halliday NJ, Harper KW, Brogden RN. Midazolam. A review of its pharmacological properties and therapeutic use. Drugs. 1984;28(6):519\u201343.","journal-title":"Drugs"},{"issue":"6","key":"1122_CR17","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/00007691-200412000-00010","volume":"26","author":"F Bremer","year":"2004","unstructured":"Bremer F, Reulbach U, Schwilden H, Schuttler J. Midazolam therapeutic drug monitoring in intensive care sedation: a 5-year survey. Ther Drug Monit. 2004;26(6):643\u20139.","journal-title":"Ther Drug Monit"},{"issue":"3","key":"1122_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/clpt.1988.31","volume":"43","author":"H Oldenhof","year":"1988","unstructured":"Oldenhof H, de Jong M, Steenhoek A, Janknegt R. Clinical pharmacokinetics of midazolam in intensive care patients, a wide interpatient variability? Clin Pharmacol Ther. 1988;43(3):263\u20139.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"1122_CR19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1592\/phco.27.3.389","volume":"27","author":"SP Spina","year":"2007","unstructured":"Spina SP, Ensom MH. Clinical pharmacokinetic monitoring of midazolam in critically ill patients. Pharmacotherapy. 2007;27(3):389\u201398.","journal-title":"Pharmacotherapy"},{"key":"1122_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40560-018-0331-7","volume":"6","author":"RJ Nies","year":"2018","unstructured":"Nies RJ, Muller C, Pfister R, Binder PS, Nosseir N, Nettersheim FS, et al. Monitoring of sedation depth in intensive care unit by therapeutic drug monitoring? A prospective observation study of medical intensive care patients. J Intensive Care. 2018;6:62.","journal-title":"J Intensive Care"},{"issue":"4","key":"1122_CR21","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1213\/ANE.0000000000005131","volume":"131","author":"CM Kapp","year":"2020","unstructured":"Kapp CM, Zaeh S, Niedermeyer S, Punjabi NM, Siddharthan T, Damarla M. The use of analgesia and sedation in mechanically ventilated patients with COVID-19 acute respiratory distress syndrome. Anesth Analg. 2020;131(4):e198\u2013200.","journal-title":"Anesth Analg"},{"key":"1122_CR22","doi-asserted-by":"crossref","unstructured":"Tapaskar N, Colon Hidalgo D, Koo G, Shingada K, Rao S, Rodriguez R, et al. Sedation usage in COVID-19 acute respiratory distress syndrome: a multicenter study. Ann Pharmacother. 2021:10600280211021925.","DOI":"10.1177\/10600280211021925"},{"issue":"4","key":"1122_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1056\/NEJMra1800222","volume":"380","author":"JAJ Martyn","year":"2019","unstructured":"Martyn JAJ, Mao J, Bittner EA. Opioid tolerance in critical illness. N Engl J Med. 2019;380(4):365\u201378.","journal-title":"N Engl J Med"},{"issue":"4","key":"1122_CR24","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0749-0704(05)70183-4","volume":"17","author":"CC Young","year":"2001","unstructured":"Young CC, Prielipp RC. Benzodiazepines in the intensive care unit. Crit Care Clin. 2001;17(4):843\u201362.","journal-title":"Crit Care Clin"},{"issue":"16","key":"1122_CR25","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","volume":"384","author":"R-C Investigators","year":"2021","unstructured":"Investigators R-C, Gordon AC, Mouncey PR, Al-Beidh F, Rowan KM, Nichol AD, et al. Interleukin-6 receptor antagonists in critically ill patients with Covid-19. N Engl J Med. 2021;384(16):1491\u2013502.","journal-title":"N Engl J Med."},{"issue":"1","key":"1122_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12879-020-4781-x","volume":"20","author":"A Abdulla","year":"2020","unstructured":"Abdulla A, Ewoldt TMJ, Hunfeld NGM, Muller AE, Rietdijk WJR, Polinder S, et al. The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial. BMC Infect Dis. 2020;20(1):57.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"1122_CR27","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00134-017-4780-6","volume":"43","author":"T T\u00e4ngd\u00e9n","year":"2017","unstructured":"T\u00e4ngd\u00e9n T, Ramos Mart\u00edn V, Felton TW, Nielsen EI, Marchand S, Br\u00fcggemann RJ, et al. The role of infection models and PK\/PD modelling for optimising care of critically ill patients with severe infections. Intensive Care Med. 2017;43(7):1021\u201332.","journal-title":"Intensive Care Med"},{"issue":"12","key":"1122_CR28","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s00228-007-0365-6","volume":"63","author":"MF Fromm","year":"2007","unstructured":"Fromm MF, Schwilden H, Bachmakov I, K\u00f6nig J, Bremer F, Sch\u00fcttler J. Impact of the CYP3A5 genotype on midazolam pharmacokinetics and pharmacodynamics during intensive care sedation. Eur J Clin Pharmacol. 2007;63(12):1129\u201333.","journal-title":"Eur J Clin Pharmacol"}],"updated-by":[{"DOI":"10.1007\/s40262-024-01389-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000}}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-022-01122-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40262-022-01122-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-022-01122-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T11:29:30Z","timestamp":1719574170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40262-022-01122-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,10]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["1122"],"URL":"https:\/\/doi.org\/10.1007\/s40262-022-01122-5","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s40262-024-01389-w","asserted-by":"object"}]},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,10]]},"assertion":[{"value":"15 March 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2024","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40262-024-01389-w","URL":"https:\/\/doi.org\/10.1007\/s40262-024-01389-w","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The medical research ethics committee approved the study and waived informed consent requirement for observational research (MEC 2020-0381).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Data is available upon request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Data is available upon request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors contributed to the study conception and design. Material preparation were performed by TJLS and AJV and data collection were performed by TJLS and SDTS. The data analyses were performed by SDTS, the manuscript was written by TJLS and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors' contributions"}}]}}